Press release
Alzheimer's Drugs Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers
Alzheimer's Drugs Market
As Alzheimer's disease becomes more prevalent, it is anticipated that the Alzheimer's drugs market will grow in response. Alzheimer's disease is a neurologic disorder that causes brain atrophy and cell death, progressively worsening over time. Alzheimer's medication is utilized to counteract memory loss, cognitive and reasoning issues, and difficulties in executing daily activities. These drugs can improve life quality and assist in maintaining independence. In a report issued by the Alzheimer's Association, a US-based nonprofit organization focused on Alzheimer's care, support, and research, in May 2024, it was discovered that the count of American seniors aged 65 and older with an Alzheimer's dementia diagnosis went up from 6.5 million in 2022 to an estimated 6.9 million in 2024. Hence, the escalating prevalence of Alzheimer's disease is fueling the expansion of the Alzheimer's drugs market.
Get Your Alzheimer's Drugs Market Report Here:
https://www.thebusinessresearchcompany.com/report/alzheimers-drugs-global-market-report
How will the growth rate of the alzheimer's drugs market shape industry trends by 2034?
Recent years have seen a substantial increase in the size of the Alzheimer's drugs market. It is projected to expand from a value of $9.33 billion in 2024 to $10.19 billion in 2025, indicating a compound annual growth rate (CAGR) of 9.1%. Factors like a surge in the number of Alzheimer's disease incidences, increased research and development funding, enhanced disease mechanism comprehension, global health drives, and rising public awareness and education have significantly contributed to the historical period's growth.
The market size of Alzheimer's drugs is predicted to experience substantial expansion in the upcoming years, with a value expected to reach $14.47 billion in 2029, at a compound annual growth rate (CAGR) of 9.2%. The predicted growth in the forecast period is attributed to the precision in medicinal approaches, targeted disease alteration, the identification and approval of biomarkers, drug development centered around the patient, as well as non-pharmacological interventions. Key trends during this forecast period include a variety of therapeutic methods, advancements in digital health solutions and diagnostic technologies, the use of artificial intelligence (AI) for drug discovery, regenerative medicine, and the increase in collaborations and partnerships.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9040&type=smp
What trends are poised to drive the future success of the alzheimer's drugs market?
Leading businesses in the Alzheimer's drugs industry are pioneering groundbreaking products such as amyloid plaque-targeting therapies to enhance treatment methods and elevate patient results. This form of therapy concentrates on minimising or impeding the collection of amyloid-beta plaques in the brain, a characteristic of Alzheimer's disease. To exemplify, in June 2024, the United States-based pharmaceutical enterprise Eli Lilly and Company received the green light for Kisunla (donanemab-azbt) from the US-based public health guardians, the Food and Drug Administration (FDA). Kisunla (donanemab-azbt) holds the distinction of being the first and sole amyloid plaque-targeting treatment for early symptomatic Alzheimer's disease and functions by helping the body eliminate residual amyloid plaques from the brain, factors that contribute to cognitive deterioration in Alzheimer's patients. The drug is delivered as an intravenous infusion every four weeks with an initial dosage regimen of 700 mg for the initial three doses, escalating to 1400 mg thereafter. Kisunla is exclusively prescribed for adults with mild cognitive impairment (MCI) and mild dementia phases of Alzheimer's disease, yet only those with a verified amyloid pathology.
Which primary segments of the alzheimer's drugs market are driving growth and industry transformations?
The alzheimer's drugs market covered in this report is segmented -
1) By Drugs: Donepezil, Rivastigmine, Galantamine, Memantine
2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
3) By Application: Early To Moderate Stages, Moderate To Severe Stages
Subsegments:
1) By Donepezil: Oral Tablets, Oral Solution
2) By Rivastigmine: Oral Capsules, Oral Solution, Transdermal Patches
3) By Galantamine: Oral Tablets, Oral Solution, Extended-Release Capsules
4) By Memantine: Oral Tablets, Oral Solution, Extended-Release Capsules
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9040
Which geographical regions are pioneering growth in the alzheimer's drugs market?
North Americawas the largest region in the Alzheimer's drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the Alzheimer's drugs market during the forecast period. The regions covered in the Alzheimer's drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Who are the influential players reshaping the alzheimer's drugs market landscape?
Major companies operating in the alzheimer's drugs market include AbbVie Inc., Daiichi Sankyo Company Limited, F Hoffmann-La Roche AG, Merck & Co Inc., Novartis AG, Biogen Inc., AstraZeneca PLC, Eisai Co Ltd., Eli Lilly and Company, H Lundbeck A/S, Pfizer Inc., Allergan PLC., Johnson & Johnson, Lupin Pharmaceuticals Inc., Actiza Pharmaceutical Private Limited, Neurotrope Inc., AC Immune SA, Adamas Pharmaceuticals Inc, Alzheon Inc., Anavex Life Sciences Corp, Axsome Therapeutics Inc., Cassava Sciences Inc., Cognition Therapeutics Inc., Cortexyme Inc., Denali Therapeutics Inc, EIP Pharma Inc., Enlivex Therapeutics Ltd., FORUM Pharmaceuticals Inc., Genentech Inc., Green Valley Pharmaceuticals LLC, Intra-Cellular Therapies Inc., Karuna Therapeutics Inc., Neurim Pharmaceuticals Ltd
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=9040&type=smp
What Is Covered In The Alzheimer's Drugs Global Market Report?
• Market Size Forecast: Examine the alzheimer's drugs market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the alzheimer's drugs market for a structured understanding.
• Key Players Overview: Analyze major players in the alzheimer's drugs market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the alzheimer's drugs market.
• Segment Contributions: Evaluate how different segments drive overall growth in the alzheimer's drugs market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the alzheimer's drugs market.
• Industry Challenges: Identify potential risks and obstacles affecting the alzheimer's drugs market.
• Competitive Landscape: Review strategic developments in the alzheimer's drugs market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Alzheimer's Drugs Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers here
News-ID: 3889328 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Alzheimer
Dementia - Alzheimer Disease Market: A Comprehensive Analysis 2030
Dementia and Alzheimer's disease represent significant challenges within the global healthcare sector. These neurological disorders, characterized by progressive cognitive decline, have seen increasing prevalence due to aging populations worldwide. This growing burden has spurred interest in the Dementia - Alzheimer's disease market, encompassing diagnostic tools, treatments, caregiving solutions, and related healthcare services. This article provides an overview of the market, its scope, current trends, and factors driving its expansion.
Data Bridge…
Alzheimer Disease Treatment Market | Allergan, Amgen, Daiichi Sankyo, Eisai
The global alzheimer disease treatment market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the alzheimer disease treatment market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
United States Alzheimer Drugs Market Insights Deep Analysis 2023-2031
Cognate Life Sciences introduces a report on "United States Alzheimer Drugs Market 2023" with Market Insights Reports, Introduces systematic details in terms of market valuation, market size, revenue estimation, and geographical spectrum of the business vertical. The study also talks about crucial pockets of the industry such as products or services offered, downstream fields, end using customers, historic data figures regarding revenue and sales, market context and more. It conjointly…
Global Alzheimer Market, Global Alzheimer Industry, Covid-19 Impact Global Alzhe …
Alzheimer's is a progressive disease that leads to the death of brain cells, resulting in memory loss, behavioral issues, and disruption the thought processes. The Alzheimer disease is considered fatal. Age and heredity are the two main risk factors for developing Alzheimer's disease. Several other preventable risk factors have been associated to the development of this disease, including diet, environment, and overall general health. A combination of risk factors is…
US Alzheimer Drug Pipeline Analysis
In US, the Alzheimer's disease is the 6th leading cause of death overall and among those aged 65 and above, it is the 5th leading cause of death. While the deaths from major diseases, like heart disease have decreased, the death due to Alzheimer's have increased by more than 60% between 2000 and 2012. The total number of patients having Alzheimer’s disease was 5.4 million in 2012. Out of this,…
Global Alzheimer Market Report: 2015 Edition | Now Available at Researchmoz.us
Researchmoz added Most up-to-date research on "Global Alzheimer Market Report: 2015 Edition" to its huge collection of research reports.
Alzheimer’s disease is defined as an advanced neurological disorder that increasingly deprives patients of their memory and ability to carry out daily activities. As it grows in a human brain, individuals are likely to practice difficulties in linguistic, agility and insight along with negative changes in the character and performance such as…
